BTG plc (BTG) Insider Rolf Soderstrom Sells 22,624 Shares of Stock

BTG plc (LON:BTG) insider Rolf Soderstrom sold 22,624 shares of the firm’s stock in a transaction that occurred on Friday, June 9th. The stock was sold at an average price of GBX 649 ($8.21), for a total transaction of £146,829.76 ($185,742.90).

Rolf Soderstrom also recently made the following trade(s):

  • On Thursday, June 1st, Rolf Soderstrom sold 129,514 shares of BTG plc stock. The stock was sold at an average price of GBX 655 ($8.29), for a total transaction of £848,316.70 ($1,073,139.41).
COPYRIGHT VIOLATION WARNING: “BTG plc (BTG) Insider Rolf Soderstrom Sells 22,624 Shares of Stock” was first published by Mideast Time and is the property of of Mideast Time. If you are accessing this article on another site, it was illegally stolen and reposted in violation of United States and international copyright & trademark legislation. The correct version of this article can be accessed at https://www.mideasttime.com/btg-plc-btg-insider-rolf-soderstrom-sells-22624-shares-of-stock/1777677.html.

BTG has been the subject of a number of recent analyst reports. Numis Securities Ltd restated a “buy” rating and set a GBX 900 ($11.39) price target on shares of BTG plc in a report on Tuesday, April 4th. Panmure Gordon restated a “buy” rating and set a GBX 737 ($9.32) price target on shares of BTG plc in a report on Thursday, April 20th. J P Morgan Chase & Co reaffirmed a “neutral” rating and set a GBX 790 ($9.99) price objective on shares of BTG plc in a research report on Tuesday, March 21st. Peel Hunt reaffirmed a “hold” rating and set a GBX 630 ($7.97) price objective on shares of BTG plc in a research report on Friday, February 24th. Finally, Stifel Nicolaus reaffirmed a “buy” rating and set a GBX 725 ($9.17) price objective on shares of BTG plc in a research report on Tuesday, April 4th. Three equities research analysts have rated the stock with a hold rating and six have issued a buy rating to the stock. The company has an average rating of “Buy” and an average price target of GBX 762 ($9.64).

BTG plc Company Profile

BTG plc is engaged in the business of healthcare, focusing on Interventional Medicine therapies for liver cancer, emphysema and vascular disorders, specialty pharmaceuticals for acute care uses, and a licensing business. The Company operates through three segments: Interventional Medicine, Specialty Pharmaceuticals and Licensing.new TradingView.widget({ “height”: 400, “width”: 625, “symbol”: “LSE:BTG”, “interval”: “D”, “timezone”: “Etc/UTC”, “theme”: “White”, “style”: “1”, “locale”: “en”, “toolbar_bg”: “#f1f3f6”, “enable_publishing”: false, “hideideas”: true, “referral_id”: “2588”});

Receive News & Ratings for BTG plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BTG plc and related companies with MarketBeat.com's FREE daily email newsletter.



Leave a Reply

 
© 2006-2017 Mideast Time.